Recombinant Human PSMB3 Protein，His

PSMB3 is a crucial component of the 26S proteasome, a multi-subunit protease complex responsible for the degradation of ubiquitinated proteins within eukaryotic cells. This protein, belonging to the β-type subunit family, plays a significant role in maintaining cellular homeostasis by regulating protein turnover, which is essential for various biological processes, including cell cycle progression, immune response, and signal transduction. Dysregulation of the proteasome, particularly involving PSMB3, has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. Recent studies have focused on the potential of PSMB3 as a therapeutic target, as its inhibition can lead to the accumulation of pro-apoptotic factors in malignant cells, thereby enhancing the efficacy of existing cancer treatments. Additionally, the ability to produce and purify recombinant PSMB3 protein has opened avenues for structural and functional analyses, facilitating a better understanding of its role in the proteasome's activity and its interactions with proteasome inhibitors. These insights may contribute to the development of novel therapeutic strategies that exploit the vulnerabilities associated with altered proteasomal functions in disease states. Overall, the study of PSMB3 recombinant protein not only enhances our fundamental knowledge of proteasome biology but also holds promise for innovative approaches in targeted therapies, particularly in oncology.